5 April 2019

Judith Prins, full professor of Medical Psychology and prominent principal investigator, has been appointed scientific director ad interim (a.i.) of the Radboud Institute for Health Sciences (RIHS) as of 1 April. She succeeds Bart Kiemeney, who will focus on carrying out research and teaching again after his RIHS directorship of more than seven years.

Judith Prins (1958) has been connected with Radboud university medical center since 1986. Trained as a developmental psychologist, Judith worked at the Center for Pediatric Oncology until 1989. From 1991-1996 she specialized as a clinical psychologist at our hospital. After her doctorate in 2003, Judith held several positions at the Department of Medical Psychology including supervisor, tutor, patient care coordinator and eventually full professor. She was appointed interim head of the department in 2007, followed by an appointment as head of the Department and full professor of Medical Psychology (2009). Her clinical and scientific focus is psycho-oncology. Judith has edited several text books and has (co)written 180 publications. Judith holds several positions at the International Society of Behavioral Medicine. In addition, she has been a member or board member for organizations such as the Radboud Foundation AYA and the Scientific Board of the Dutch Cancer Society.

“We are very pleased that such a prominent principal investigator, with remarkable experience in the fields of research, education and patient care, will hold the position of scientific director a.i. of the Radboud Institute for Health Sciences”, states Paul Smits, chair of the Executive Board and dean of Radboud university medical center.

 

Related news items


Social media posts on medication use during pregnancy often incorrect

23 August 2019

Dutch social media regularly post about the safety of medicines for pregnant women. Many pregnant women use these posts as a source of information. A new analysis shows, however, that information found on social media about the risk of medication use often does not correspond with guidelines.

read more

Hans van Bokhoven newly elected in Academia Europaea

22 August 2019

The Academia Europaea is a functioning European Academy of Humanities, Letters and Sciences, composed of individual members.

read more

Drug-induced interstitial lung disease in advanced breast cancer patients receiving everolimus

22 August 2019

In Targeted Oncology, Annelieke Willemsen, Carla van Herpen and colleagues, showed that pulmonary function test with diffusion capacity of the lungs for carbon monoxide and serum biomarkers can be of aid to differentiate everolimus-related interstitial lung disease from other respiratory problems.

read more

Publication in PNAS on dissecting EEC syndrome using single-cell RNA-seq

22 August 2019

PhD candidates Eduardo Soares and Quan Xu in Jo Huiqing Zhou’s group in Molecular Developmental Biology, theme Reconstruction and regenerative medicine, have published a paper in PNAS on the disease mechanism of EEC syndrome using single-cell RNA-seq technology and patient-derived iPSCs.

read more

Patient trust and participation in cell biological research

21 August 2019

Alessandra Cambi and Gert Olthuis, discuss key ethical issues inherent in the development and the value of building trust and trustworthiness.

read more

NWO grant for a tissue-generating patch to close diaphragmatic defects

21 August 2019

Willeke Daamen and Toin van Kuppevelt, theme Reconstructive and regenerative medicine, were recently awarded a 690 k€ grant by NWO, domain Applied & Engineering Sciences, for the development of advanced patches for closure of diaphragmatic defects in children with congenital diaphragmatic hernia.

read more